• Tyler Carr and Richard Gillum.
• MSII, Howard University College of Medicine, 520 W St NW, Washington, DC 20059, USA. Electronic address: tyler.carr@bison.howard.edu.
• J Natl Med Assoc. 2023 Jun 1; 115 (3): 314318314-318.

BackgroundIn the US, little is known about aspirin use as a preventive measure for cardiovascular disease by immigration status.MethodsCombined data from the National Health and Nutrition Examination Survey (NHANES) 2015-2016 and 2017- March 2020 (pre-pandemic data) were analyzed. Persons were asked about demographics including country of birth and those aged 40 years and older were asked about current use of aspirin to prevent cardiovascular disease (CVD).ResultsAmong 2,321 born in the US, preventive aspirin use was significantly more prevalent (39.6%) than among 910 others (27.5%, p < 0.01). However, after stratifying by race/ethnicity and history of CVD, the difference was significant only in Hispanics with CVD. In logistic regression analyses in Hispanics controlling for age, gender and education, the US born had significantly higher odds of aspirin use in those with or without CVD.DiscussionAmong US Hispanics, use of aspirin for prevention of CVD was more prevalent in those born in the US than in others.Copyright © 2023 National Medical Association. Published by Elsevier Inc. All rights reserved.

21 keywords...

hide…